TBTianhao Bao

Tianhao Bao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tianhao Bao has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Haoran Xing

    Department of Research and Education, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan, People’s Republic of China

    2 shared publications
  • Jie Wu

    The Affiliated Mental Health Center Kunming Medical University Kunming Yunnan China

    2 shared publications
  • Yanjun Wang

    Department of Research and Education, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan Province, China

    2 shared publications
  • Yingying Zhang

    Department of Research and Education, The Affiliated Mental Health Center of Kunming Medical University, Kunming, Yunnan, People’s Republic of China

    2 shared publications
  • Yingying Zhang

    Department of Science and Education , 71240 Kunming Medical University Affiliated Mental Health Center , Yunnan Province Mental Hospital, Kunming , 650224 , People’s Republic of China

    2 shared publications
  • Zijun Liu

    The Second Affiliated Hospital of Kunming Medical University, Yunnan Key Laboratory of Neuropsychiatric Disorders Kunming Yunnan China

    2 shared publications

Latest Publications

  • 6.42 Million Tests Reviewed: Analysis of Critical Value Evolution Characteristics and Therapeutic Drug Monitoring Warning Value in a Psychiatric Hospital Over 10 Years

    by Shu Yang, Haoran Xing, Weiqun Shen, Yanjun Wang, Qian Deng, Xiaoyong He, Tianhao Bao

    Background: Critical values in laboratory testing and alert values for therapeutic drug monitoring (TDM) are essential for clinical safety and psychotropic drug optimization, yet their distribution, associated factors, and clinical significance in psychiatric specialty hospitals remain insufficiently characterized. Therefore, we aimed to determine these parameters to provide a theoretical basis for optimizing critical value management and psychotropic drug use. Method: A retrospective analysis was conducted on critical value reports from the clinical laboratory and TDM alert value data of inpatients and outpatients at the Affiliated Mental Health Center of Kunming Medical University from January 2016 to December 2025. The incidence of critical and TDM alert values, sex and age differences, project composition ratios, and distributions by ward and disease diagnoses were analyzed. Results: A total of 3700 reports of critical and TDM alert values were included with 27.27% older than 65 years (63.49% female and 36.51% male). Among the categories of hematological routine, biochemical, coagulation critical values, and hematological drug concentration monitoring warning values, hematological drug concentration monitoring warning values accounted for the highest proportion. (49.73%) and among individual test items, the top‑five items were: white blood cell count (15.89%), serum potassium (8.87%), myoglobin (7.06%), glucose (6.27%), and TDM venlafaxine and its metabolites (5.81%). The critical and TDM alert values came from the geriatric psychiatry (1220 cases; 32.97%), outpatient (803 cases; 21.70%), and sleep medicine (8.08%) departments. Conclusions: In this psychiatric specialty hospital, Among the categories of hematological routine, biochemical, coagulation critical values, and hematological drug concentration monitoring warning values, hematological drug concentration monitoring warning values accounted for the highest proportion. The predominant individual issues included leukopenia, hypokalemia, hyperglycemia, and elevated venlafaxine metabolite levels, which may be associated with the adverse effects of psychotropic medications, patient adherence, and comorbid physical illnesses. Individualized critical and TDM alert value thresholds should be determined based on specific characteristics to provide healthcare professionals with reference criteria for assessing disease severity to improve the quality of critical value management and medication use and reducing the incidence of adverse outcomes.

  • Open Access

    Peripheral lncRNA–IL1RAP Dysregulation in Schizophrenia: A Multi‐Omics Bridge Between Immunity and Diagnosis

    by Jie Wu, Ruize Niu, Zijun Liu, Yuanyuan Li, Yunqiao Zhang, Zhaowei Teng, Yong Zeng, Tianhao Bao

    Background: Schizophrenia (SCZ) is frequently accompanied by peripheral immune dysregulation, yet robust and reproducible blood‐based molecular markers remain limited. Objective: We sought a compact long non‐coding RNA (lncRNA) signal in peripheral blood leukocytes (PBL) and examined how it aligns with immune‐linked transcriptional programs and cellular compartments, using bulk RNA sequencing (RNA‐seq), targeted validation, and a healthy‐donor peripheral blood mononuclear cell (PBMC) single‐cell reference for localization. Methods: PBL from 50 first‐episode or unmedicated SCZ patients and 50 matched controls underwent RNA‐seq. We performed reference‐guided transcript annotation and generated lncRNA and mRNA count matrices. Differential expression was assessed with edgeR (TMM normalization). Candidate lncRNAs were prioritized using sample‐level lncRNA‐mRNA co‐variation, followed by qRT–PCR validation in an independent cohort and evaluation with a two‐feature logistic regression model using repeated 10‐fold cross‐validation. Pathway‐scale analyses and weighted gene co‐expression network analysis (WGCNA) summarized coordinated programs. Single‐cell data from healthy donors were used for expression localization only, not case‐control testing. Results: We observed a small set of dysregulated lncRNAs alongside broader mRNA changes. Two candidates at the CCR3 and IL1RAP loci (TCONS_00134168/lncRNA–CCR3 and TCONS_00138311/lncRNA–IL1RAP) showed consistent case–control directionality and were supported by qRT–PCR. The two‐lncRNA model showed strong internal discrimination (AUC = 0.933) but weaker, uncertain performance in a small external qRT–PCR set (AUC = 0.656). Enrichment analyses highlighted synapse‐related annotations, RNA processing/translation, and immune signaling, with recurrent involvement of IL1RAP‐linked IL‐1 branches. WGCNA placed lncRNA–IL1RAP and IL1RAP within diagnosis‐inversely associated co‐expression programs, whereas lncRNA–CCR3 showed a more transcript‐specific pattern. In the healthy‐reference single‐cell atlas, IL1B/IL1RAP/HSF1 signals were most prominent in the monocyte/macrophage compartment. Conclusion: Together, these findings support an exploratory two‐lncRNA candidate marker concept, while underscoring the need for larger multi‐center validation and targeted mechanistic follow‐up without implying causality.

  • Open Access

    Imbalance of the Brain–Gut–Microbiota Axis in Major Depressive Disorder: From Pathogenesis to Clinical Translation

    by Tao Wu, Haoran Xing, Tianzhong Wu, Xian Xie, Long Ji, Wei Wang, Xiaolina Zhang, Yingying Zhang, Chengrong Jiang, Tianhao Bao

    Major depressive disorder (MDD) is one of the most common psychiatric conditions, characterized by complex pathogenesis and marked inter-individual variability in treatment response, leading to persistent impairment of physical and mental health as well as social functioning. In recent years, the brain–gut–microbiota axis (BGMA) has emerged as a key biological pathway linking the gut microbiota with the central nervous system, and its role in MDD has become a major research focus. Although substantial progress has been made in elucidating the association between MDD and the BGMA, the precise mechanisms, critical pathways, and their integrated clinical applications remain to be fully clarified. On the basis of a comprehensive overview of the physiological functions, structural components, and disease associations of the BGMA, this review systematically summarizes the bidirectional interactions between MDD and the BGMA. Integrating the latest findings from preclinical and clinical studies, we further dissect the key regulatory pathways of this axis in MDD and highlight the therapeutic potential of BGMA-based interventions, including pharmacotherapy, fecal microbiota transplantation, dietary modulation, and physical therapies. This work aims to provide a theoretical foundation for developing novel treatment strategies for patients with MDD and for improving their prognosis and quality of life.


  • Open Access

    Association between endogenous lactate accumulation and dysregulated activation of the NLRP3 inflammasome pathway in schizophrenia

    by Yingying Zhang, Yanjun Wang, Haoran Xing, Yuncheng Bai, Mier Li, Haiqiang Zhao, Luanmei Ding, Weiwei Wang, Tianhao Bao

    In this study, we retrospectively analyzed whether serum lactate levels were elevated in patients with schizophrenia (SCZ) and explored cognitive deficits, abnormalities in lactate metabolism, and neuroinflammation in an dizocilpine (MK-801)-induced N-methyl-d-aspartate (NMDA) receptor (NMDAR) inhibition model using the Morris water maze (MWM) test, biochemical assays, immunofluorescence (IF), Western blot (WB), and enzyme-linked immunosorbent assay (ELISA). We found that serum lactate levels were significantly higher than the normal range in patients with schizophrenia, and they were significantly and positively correlated with both length of hospitalization and serum triglyceride levels. In addition, we found that MK-801 induced cognitive deficits in Sprague-Dawley (SD) rats, accompanied by markedly elevated levels of lactate, pyruvate, glutamate and lactate dehydrogenase (LDH) activity in serum and frontal cortex (FCX). MK-801 caused a significant increase in the expression of NOD-, LRR-, and pyrin-containing protein 3 (NLRP3) and Caspase-1 proteins in FCX of rats; and elevated the levels of interleukin (IL)-1β and IL-18 in serum and FCX (P<0.05). We also found that serum lactate was significantly and positively correlated with serum pyruvate and glutamate levels, LDH activity, and IL-1β and IL-18 levels in SD rats. These data suggest that serum lactate is abnormally elevated in both SCZ patients and NMDA receptor inhibition models. Furthermore, there may be a link between MK-801-induced cognitive impairment, elevated serum lactate, and aberrant activation of the NLRP3/Caspase-1/IL-1βinflammatory pathway in rats. Modulation of serum/brain lactate levels and the NLRP3/Caspase-1/IL-1β pathway in SCZ patients may serve as potential targets for improving cognitive impairment in SCZ. Clinical trial registration number: ChiCTR2400091186.


  • Advances in repetitive transcranial magnetic stimulation in the treatment of treatment-resistant depression: a comprehensive review

    by Haoran Xing, Xiaolei Liu, Yingying Zhang, Jie Wu, Mier Li, Hong Ye, Yu Ding, Weiwei Wang, Zhong Zheng, Tianhao Bao

    Major depressive disorder is a common mental disorder, and a significant number of patients exhibit poor response to conventional antidepressant treatments, known as treatment-resistant depression (TRD). However, the definition of TRD globally remains unclear, impeding clinical research, treatment development, outcome implementation, and policy-making. A wealth of research confirms that rTMS demonstrates promising efficacy in TRD. This paper elucidates the definition of TRD, summarizes potential targets of rTMS for treating TRD, comprehensively elaborates on the unique mechanisms, efficacy, and side effects of rTMS in treating TRD, and outlines considerations for special populations receiving rTMS treatment for TRD as well as other treatment modalities for TRD. Through these studies, we aim to provide more scientifically grounded recommendations for patients undergoing rTMS treatment for TRD.


  • Open Access

    Longitudinal Relationship Between Psychological Capital and Anxiety in College Students: The Mediating Effect of Emotion Reregulation Strategy and Moderating Effect of Parent-Child Relationship

    by Zijun Liu, Tianhao Bao, Zhilan Yang, Ye Ruan, Changqing Gao, Jie Wu

    Objective: Based on Conservation of resources theory, process model of emotion regulation and attachment theory, the present study examined how psychological capital affects anxiety through the mediation of emotion regulation strategies and explored the moderating role of parent-child relationship. Methods: Using a longitudinal study method, 962 college students were surveyed twice at one-year intervals. Results: (1) College students’ emotion regulation strategies (including cognitive reappraisal and expressive suppression) partially mediated psychological capital and anxiety mood; (2) parent-child relationship moderated the pathways of psychological capital and expressive suppression on anxiety, respectively. Conclusion: College students with higher levels of parent-child relationship had stronger predictive effects of psychological capital and weaker predictive effects of expressive suppression on anxiety mood. The research findings clarify the combined effects of emotion regulation and parent-child relationships on anxiety among college students, providing valuable reference for the design and implementation of interventions to promote individual psychological well-being.


  • Progress in The Research of Lactate Metabolism Disruption And Astrocyte‐Neuron Lactate Shuttle Impairment in Schizophrenia: A Comprehensive Review

    by Yingying Zhang, Liang Tong, Li Ma, Hong Ye, Shue Zeng, Shaochuan Zhang, Yu Ding, Weiwei Wang, Tianhao Bao

    Schizophrenia (SCZ) is a complex neuropsychiatric disorder widely recognized for its impaired bioenergy utilization. The astrocyte‐neuron lactate shuttle (ANLS) plays a critical role in brain energy supply. Recent studies have revealed abnormal lactate metabolism in SCZ, which is associated with mitochondrial dysfunction, tissue hypoxia, gastric acid retention, oxidative stress, neuroinflammation, abnormal brain iron metabolism, cerebral white matter hypermetabolic activity, and genetic susceptibility. Furthermore, astrocytes, neurons, and glutamate abnormalities are prevalent in SCZ with abnormal lactate metabolism, which are essential components for maintaining ANLS in the brain. Therefore, an in‐depth study of the pathophysiological mechanisms of ANLS in SCZ with abnormal lactate metabolism will contribute to a better understanding of the pathogenesis of SCZ and provide new ideas and approaches for the diagnosis and treatment of SCZ.


  • Depression and Bipolar Affective Disorder

    by Zhong Zheng, Ke Zou, Jiaxi Huang, Tianhao Bao, Jiaqi Han